infectious diseases
Pneumococcal Vaccine
Indications forPneumococcal Vaccine
Children up to 18 years of ageshould receive thepneumococcal vaccine. For detailed information on administering thepneumococcal vaccineto children seeCDC: Pneumococcal Vaccination: Summary of Who and When to VaccinateandCDC: Child and Adolescent Immunization Schedule by Age). Adults age 65 years or olderwho have not previously received a pneumococcal conjugate vaccine or whose vaccination history is unknown should receive either 1 dose of PCV20or 1 dose of PCV15 followed by a dose of PPSV23 Adults 19 to 64 yearswho have certain medical conditions or other risk factors and who have not previously received a pneumococcal conjugate vaccine or whose vaccination history is unknown should receive either 1 dose of PCV20 OR 1 dose of PCV15 followed by a dose of PPSV23 The applicable medical conditions and risk factors include the following: Alcohol use disorder Chronic heart, lung, or liver disease Chronic renal failure or nephrotic syndrome Cigarette smoking Cochlear implant Congenital or acquired asplenia Cerebrospinal fluid leak Diabetes mellitus Generalized cancer HIV Hodgkin disease Immunodeficiency or immunosuppression Leukemia, lymphoma, or multiple myeloma Solid organ transplants Sickle cell disease or other hemoglobinopathies For both adult age groups,the dose of PPSV23 should follow the dose of PCV15 by at least 1 year. A minimum interval of 8 weeks between PCV15 and PPSV23 can be considered for adults with an immunocompromising condition, cochlear implant, or cerebrospinal fluid (CSF) leak. Also, for those who have previously received a dose ofpneumococcal vaccine, see detailed recommendations regarding furtherpneumococcal vaccinedosing atCDC: Pneumococcal Vaccination: Summary of Who and When to VaccinateandCDC: Adult Immunization Schedule by Age. 